Decrease in formalin-inactivated respiratory syncytial virus (FI-RSV) enhanced disease with RSV G glycoprotein peptide immunization in BALB/c mice.

Respiratory syncytial virus (RSV) is a high priority target for vaccine development. One concern in RSV vaccine development is that a non-live virus vaccine would predispose for enhanced disease similar to that seen with the formalin inactivated RSV (FI-RSV) vaccine. Since a mAb specific to RSV G pr...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Gertrud U Rey, Congrong Miao, Hayat Caidi, Suvang U Trivedi, Jennifer L Harcourt, Ralph A Tripp, Larry J Anderson, Lia M Haynes
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Public Library of Science (PLoS) 2013-01-01
Colecção:	PLoS ONE
Acesso em linha:	http://europepmc.org/articles/PMC3871585?pdf=render
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!